bpc 157 dosing protocol human bpc-157 BPC-157 Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved Integrative Peptides BPC-157: complete guide
Description
Metformin induces reductions in plasma cobalamin and haptocorrin bound cobalamin levels in elderly diabetic patients
He also cites studies done in rodents and worms to show that methylene blue improves brain energy use, reduces inflammation, and protects against neurological damage
Viola D, Dona A, Caserta E, et al
Borrelia burgdorferi sensu lato infection in patients with peripheral facial palsy
In the UK, your GP is the appropriate first point of contact for concerns about weight management, metabolic health, or diabetes
Phase 2b doses were 0.25 to 1.0 mg daily, which at a 2.5 mg/ml concentration means 0.1 to 0.4 ml per injection, conveniently measurable on a 1 ml insulin syringe
